Harbor Diversified (Harbor Diversified) Cash And Cash Equivalents : $15.8 Mil (As of Sep. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Harbor Diversified Cash And Cash Equivalents?

Harbor Diversified's quarterly cash and cash equivalents declined from Mar. 2023 ($22.51 Mil) to Jun. 2023 ($15.83 Mil) but then increased from Jun. 2023 ($15.83 Mil) to Sep. 2023 ($15.84 Mil).

Harbor Diversified's annual cash and cash equivalents declined from Dec. 2020 ($130.37 Mil) to Dec. 2021 ($37.17 Mil) and declined from Dec. 2021 ($37.17 Mil) to Dec. 2022 ($33.33 Mil).

Harbor Diversified Cash And Cash Equivalents Historical Data

The historical data trend for Harbor Diversified's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbor Diversified Cash And Cash Equivalents Chart

Harbor Diversified Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec18

Dec19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

Get a 7-Day Free Trial

60.26

69.45

130.37

37.17

33.33

Harbor Diversified Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash And Cash Equivalents	Get a 7-Day Free Trial															19.01	33.33	22.51	15.83	15.84

Harbor Diversified Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Harbor Diversified (OTCPK:HRBR) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Harbor Diversified Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Harbor Diversified's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbor Diversified (Harbor Diversified) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Harbor Diversified Inc (OTCPK:HRBR) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

W6390 Challenger Drive, Suite 203, Appleton, WI, USA, 54914-9120

Website

http://www.harborbiosciences.com

Harbor Diversified Inc operates in the Airline business. It currently operates in one service line providing scheduled flight services. It generates revenue from the Available Seat Miles.

Executives

John C Shaw	director	520 MADISON AVENUE, 40TH FLOOR, NEW YORK NY 10022
Jerry M Seslowe	director	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Richard A Bartlett	director	520 MADISON AVENUE, 40TH FLOOR, NEW YORK NY 10022
Scott M Freeman	officer: Chief Medical Officer	3031 RESEARCH DRIVE, BUILDING A, RICHMOND CA 94806
Salvatore J Zizza	director	810 SEVENTH AVE, 27TH FLOOR, NEW YORK NY 10019
Jessie R Groothuis	officer: Vice Pres., Clinical Affairs	4435 EASTGATE MALL, SUITE 400, SAN DIEGO CA 92121
Jerome M Hauer	director	4435 EASTGATE MALL, SUITE 400, SAN DIEGO CA 92121
Thomas Merigan	director	C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Brendan Mcdonnell	director	C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Marc R Sarni	director	13705 SHORELINE COURT, EARTH CITY MO 63045
Daniel D Burgess	officer: COO/CFO	C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Robert Marsella	officer: VP, Business Development	C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Robert W Weber	officer: Chief Accounting Officer	C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Eric J Loumeau	officer: VP, Corporate General Counsel	C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Paul Bagley	director	1530 16TH STREET SUITE 200, DENVER CO 80202-1468

Harbor Diversified (Harbor Diversified) Headlines

From GuruFocus

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Harbor Diversified, Inc. - HRBR

By PRNewswire • 04-04-2024